The American Medical Association (AMA) has released new and revised CPT Category II codes, effective Jan. 1, 2012. Category II codes are supplemental tracking codes used for performance measurement (e.g., the Physician Quality Reporting System, www.cms.gov/PQRS/).
Category II codes are not required for correct coding and should not be used in place of Category I codes. They describe clinical components that may: typically be included in evaluation and management (E/M) or clinical services; result from clinical laboratory or radiology tests and other procedures; or identify processes intended to address patient safety practices or services reflecting compliance with the state or federal law.
For 2012, four Category II codes are deleted and replaced by newer codes:
* 4002F Statin therapy, prescribed (CAD) is deleted and replaced by 4013F Statin therapy
prescribed or currently being taken (CAD).
* 4006F Beta-blocker therapy prescribed (CAD,HF) is replaced by 4008F Beta-blocker
therapy prescribed or currently being taken (CAD, HF).
* 4009F Angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB)
therapy prescribed (HF, CAD, CKD), (DM) is replaced by 4010F Angiotensin converting
enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy prescribed or
currently being taken (CAD, HF).
* 4275F Hepatitis B vaccine injection administered or previously received (HIV) is replaced by
4149F Hepatitis B vaccine injection administered or previously received (HEP C, HIV) (IBD).
Several dozen new codes have been added in clinical areas such as angina, tobacco use, neuropsych-
iatric symptoms, and more.
For a full list of revisions to Category II codes (as well as a sneak peak at some 2013 codes), see "Update to List of Category II Codes" dated Sept. 14, 2011.
No comments:
Post a Comment